Australian vaccine manufacturer CSL is currently in talks with the Federal Government about producing the University of Oxford’s promising coronavirus vaccine at its Melbourne plant.

The company, which has already partnered with the University of Queensland to help bring its protein subunit vaccine to market, now says it’s exploring whether it could simultaneously make both vaccines for domestic use.